BioCentury
ARTICLE | Company News

Metabasis endocrine, metabolic, infectious news

September 7, 2009 7:00 AM UTC

Metabasis hired Merriman Curhan Ford to assist in exploring and evaluating strategic alternatives. The biotech's MB07803 is in Phase II testing for Type II diabetes. Metabasis restructured and reduce...